​

DBV (DBVT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DBVT Stock Rating

DBV stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 0 Hold (0.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 0 3 Strong Sell Sell Hold Buy Strong Buy

DBVT Price Target Upside V Benchmarks

TypeNameUpside
StockDBV-
SectorHealthcare Stocks 25.19%
IndustryBiotech Stocks 61.26%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.44$4.44$4.44
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 252----2
Jan, 252----2
Dec, 242----2
Nov, 24441-110
Oct, 244411111
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2024H.C. WainwrightBuyBuyhold
Jul 31, 2024JMP SecuritiesOutperformOutperformhold
Jan 04, 2023Societe GeneraleHoldBuyupgrade
Dec 15, 2022Goldman SachsSelldowngrade
Apr 26, 2022Societe GeneraleHolddowngrade

Financial Forecast

EPS Forecast

$-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.95$-1.78$-1.24$-0.76-----
Avg Forecast$-3.72$-2.85$-7.68$-5.63$-4.88$-4.42$-6.35$-5.14$-2.43
High Forecast$-3.58$-2.75$-7.40$-5.36$-4.65$-4.21$-6.05$-4.90$-2.31
Low Forecast$-3.95$-3.03$-7.97$-5.90$-5.12$-4.63$-6.65$-5.39$-2.54
Surprise %-20.70%-37.54%-83.85%-86.50%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.28M$5.71M$4.80M------
Avg Forecast$10.77M$4.74M$5.70M$6.03M$3.10M$3.17M$37.55M$143.32M$317.48M
High Forecast$11.29M$4.96M$5.86M$6.25M$3.21M$3.29M$38.92M$148.55M$329.06M
Low Forecast$10.47M$4.60M$5.53M$5.81M$2.99M$3.06M$36.18M$138.09M$305.90M
Surprise %4.68%20.48%-15.72%------

Net Income Forecast

$-800M $-650M $-500M $-350M $-200M $-50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-159.56M$-97.81M$-96.30M$-72.73M-----
Avg Forecast$-353.51M$-271.47M$-730.72M$-535.68M$-464.65M$-420.57M$-604.31M$-489.12M$-230.72M
High Forecast$-340.58M$-261.54M$-703.44M$-510.28M$-442.61M$-400.63M$-575.66M$-465.93M$-219.78M
Low Forecast$-375.43M$-288.31M$-758.00M$-561.08M$-486.68M$-440.52M$-632.97M$-512.31M$-241.66M
Surprise %-54.86%-63.97%-86.82%-86.42%-----

DBVT Forecast FAQ

Is DBV stock a buy?

DBV stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that DBV is a favorable investment for most analysts.

What is DBV's price target?

DBV's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.44.

How does DBV stock forecast compare to its benchmarks?

DBV's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.19%) and underperforming the biotech stocks industry (61.26%).

What is the breakdown of analyst ratings for DBV over the past three months?

  • February 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is DBV’s EPS forecast?

DBV's average annual EPS forecast for its fiscal year ending in December 2024 is $-4.88, marking a 542.11% increase from the reported $-0.76 in 2023. Estimates for the following years are $-4.42 in 2025, $-6.35 in 2026, $-5.14 in 2027, and $-2.43 in 2028.

What is DBV’s revenue forecast?

DBV's average annual revenue forecast for its fiscal year ending in December 2024 is $3.1M, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $3.17M, followed by $37.55M for 2026, $143.32M for 2027, and $317.48M for 2028.

What is DBV’s net income forecast?

DBV's net income forecast for the fiscal year ending in December 2024 stands at $-465M, representing an 538.90% increase from the reported $-72.726M in 2023. Projections indicate $-421M in 2025, $-604M in 2026, $-489M in 2027, and $-231M in 2028.